Santen Pharmaceutical Co Ltd's ticker is SNPHY and the CUSIP is 80287P100. A total of 5 filers reported holding Santen Pharmaceutical Co Ltd in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $427,000 | -28.5% | 34,842 | -14.1% | 0.00% | – |
| Q3 2016 | $597,000 | -15.4% | 40,565 | -10.2% | 0.00% | – |
| Q2 2016 | $706,000 | -0.4% | 45,161 | -4.2% | 0.00% | – |
| Q1 2016 | $709,000 | -17.2% | 47,163 | -9.3% | 0.00% | -100.0% |
| Q4 2015 | $856,000 | +16.3% | 52,015 | -5.4% | 0.00% | – |
| Q3 2015 | $736,000 | -7.5% | 54,999 | -2.3% | 0.00% | – |
| Q2 2015 | $796,000 | -6.1% | 56,300 | +141.6% | 0.00% | – |
| Q1 2015 | $848,000 | +84700.0% | 23,304 | +77580.0% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 30 | -14.3% | 0.00% | – |
| Q2 2014 | $1,000 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHUMBLINE ADVISERS | 30 | $273 | 0.00% |